I'm just repeating what was said by Roche during the call. Just doesn't make sense why the FDA wouldn't want to approve but Roche being so tentative is somewhat telling. Do you remember why they didn't have an SPA for this in the first place?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.